FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Corn patents



      
           
This page is updated frequently with new Corn-related patent applications. Subscribe to the Corn RSS feed to automatically get the update: related Corn RSS feeds. RSS updates for this page: Corn RSS RSS


Noninvasive measurement of chemical substances

Geelux Holding

Noninvasive measurement of chemical substances

Dakota Sciences

Progressive multifocal rigid gas permeable contact lens

Date/App# patent app List of recent Corn-related patents
03/26/15
20150088104
 Operator-controlled scanning laser procedure designed for large-area epithelium removal patent thumbnailnew patent Operator-controlled scanning laser procedure designed for large-area epithelium removal
Systems and methods for removing an epithelial layer disposed over a stromal layer in a cornea irradiate a region of the epithelial layer with a pulsed beam of ablative radiation. The ablative radiation is scanned to vary the location of the beam within the region in accordance with a pulse sequence.
Amo Development, Llc.
03/26/15
20150086527
 Pharmaceutical composition for treatment of corneal endothelial wounds containing angiogenin patent thumbnailnew patent Pharmaceutical composition for treatment of corneal endothelial wounds containing angiogenin
Provided is a pharmaceutical composition for treating corneal endothelium wounds, the composition including angiogenin as an effective ingredient. The present invention relates to a new topical therapeutic use of angiogenin for treatment of corneal endothelium wounds, wherein the angiogenin that is generally known to be involved in angiogenesis activates a pi3k/akt/enos pathway thereof in ocular corneal endothelium to increase migration and proliferation of corneal endothelial cells that are not capable of self-proliferation and to promote prevention and treatment of corneal endothelial cell wounds..
Industry Academic Cooperation Foundation, Hallym University
03/26/15
20150085256
 Ophthalmological device patent thumbnailnew patent Ophthalmological device
An ophthalmological device emits light from a measurement optical system to an eye to be examined and calculates a dimension along the eye axis of a target portion of the eye from interfering light composed of reflected light from the eye and reference light. The measurement optical system includes incidence position changing member that changes the incidence position of light emitted to the eye, and driving unit that drives the incidence position changing member so as to scan at the incidence position of emitted light in a predetermined region of the eye.
Tomey Corporation
03/26/15
20150085249
 Noninvasive measurement of chemical substances patent thumbnailnew patent Noninvasive measurement of chemical substances
Utilization of a contact device placed on the eye in order to detect physical and chemical parameters of the body as well as the non-invasive delivery of compounds according to these physical and chemical parameters, with signals being transmitted continuously as electromagnetic waves, radio waves, infrared and the like. One of the parameters to be detected includes non-invasive blood analysis utilizing chemical changes and chemical products that are found in the conjunctiva and in the tear film.
Geelux Holding, Ltd.
03/26/15
20150085246
 Progressive multifocal rigid gas permeable contact lens patent thumbnailnew patent Progressive multifocal rigid gas permeable contact lens
A large diameter, rigid, gas permeable, corneal-scleral progressive, multifocal vision contacty lens that covers the cornea and a portion of the sclera of an eye. It is particularly beneficial for use on patients who have undergone refractive surgery and/or on patients experiencing presbyopia.
Dakota Sciences, Inc.
03/26/15
20150083024
 Novel dilatant fluids patent thumbnailnew patent Novel dilatant fluids
There is provided a novel adhesive shear thickening dilatant fluid and process for the formation thereof comprising the sequential steps of adding to a gel comprising starch and water and adding thereto a sufficient portion of dry solid material, suitably a starch, to form a kneadable solid which is dry to the touch. In particular it is directed to a material whose principle component is uncooked waxy corn starch..
Oobieq Ltd
03/19/15
20150080865
 Corneal inlay design and methods of correcting vision patent thumbnailCorneal inlay design and methods of correcting vision
Methods of designing corneal implants, such as inlays, to compensate for a corneal response, such as epithelial remodeling of the epithelial layer, to the presence of the implant. Additionally, methods of performing alternative corneal vision correction procedures to compensate for an epithelial response to the procedure.
03/19/15
20150080470
 Transdermal delivery of beneficial substances effected by a hostile biophysical environment patent thumbnailTransdermal delivery of beneficial substances effected by a hostile biophysical environment
The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical environment. In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed.
Strategic Science & Technologies, Llc
03/19/15
20150080350
 Bumetanide analogs, compositions and methods of use patent thumbnailBumetanide analogs, compositions and methods of use
The present invention provides bumetanide, analogs and compositions comprising such analogs. The present invention also provides pharmaceutical compositions containing these bumetanide, analogs and methods for their use.
Neuropro Therapeutics, Inc.
03/19/15
20150080330
 Method of reducing intraocular pressure in humans patent thumbnailMethod of reducing intraocular pressure in humans
Provided herein is a method of reducing intraocular pressure (iop) in humans using n6-cyclopentyladenosine (cpa), cpa derivatives or prodrugs or enhanced cornea permeability formulations of cpa. In one embodiment, the invention is directed to cpa derivatives or prodrugs that are permeable to the cornea.
Inotek Pharmaceuticals Corporation
03/19/15
20150080314

Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing


Ocular analgesics for topical administration are described. The topical ocular analgesic includes a neo-tryptophan-containing neurotensin analog.
Sloan-kettering Institute For Cancer Research
03/19/15
20150077701

Contact lenses for refractive correction


Ophthalmic lenses for correcting refractive error of an eye are disclosed. Ophthalmic lenses include a deformable inner portion and a deformable peripheral portion.
Nexisvision, Inc.
03/19/15
20150075440

Egg-holding tray for incubation


An egg-holding tray for incubation intended to accommodate eggs has rectangular shape with rounded corners bordered by parallel walls. A lower part of these walls configures a protruding rectangular border.
Pas Reform B.v.
03/12/15
20150071806

Rotary vane air motor with improved vanes and other improvements


A rotary vane air motor comprises a rotor, stator and vanes. The rotor has slots for the vanes, and the vanes may move between a retracted position and a contact position in which the vanes contact the cylinder.
Shining Golden Yida Welding & Cutting Machinery Manufacture Ltd.
03/05/15
20150066466

Systems and methods for treatment deconvolution using dual scale kernels


Deconvolution systems and methods based on cornea smoothing can be used to obtain an ablation target or treatment shape that does not induce significant high order aberrations such as spherical aberration. Exemplary ablation targets or treatment shapes can provide a post-operative spherical aberration that is equal to or below a naturally occurring amount of spherical aberration..
Amo Development, Llc
03/05/15
20150065940

Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye


Delivery devices, systems and methods are provided for inserting an implant into an eye. The delivery or inserter devices or systems can be used to dispose or implant an ocular stent or implant, such as a shunt, in communication with the suprachoroidal space, uveal scleral outflow pathway, uveoscleral outflow path or supraciliary space of the eye.
Glaukos Corporation
03/05/15
20150065837

Device for generating a detectable signal based upon concentration of at least one substance


Utilization of a contact device placed on the eye in order to detect physical and chemical parameters of the body as well as the non-invasive delivery of compounds according to these physical and chemical parameters, with signals being transmitted continuously as electromagnetic waves, radio waves, infrared and the like. One of the parameters to be detected includes non-invasive blood analysis utilizing chemical changes and chemical products that are found in the conjunctiva and in the tear film.
Geelux Holding, Ltd.
03/05/15
20150064230

Sustained release delivery of one or more agents


The lacrimal implant delivery systems and methods described herein provide for controlled release of a therapeutic agent for the treatment of disease, including the treatment of glaucoma, ocular hypertension, or elevated intraocular pressure with latanoprost or other anti-glaucoma agents. Treatment of disease, including glaucoma, ocular hypertension, or elevated intraocular pressure with latanoprost or other anti-glaucoma agent in conjunction with penetration enhancer, such as benzalkonium chloride, and/or artificial tears is also provided.
Mati Therapeutics Inc.
03/05/15
20150062529

Systems and methods for providing astigmatism correction


A method of selecting a toric lens by taking into consideration the magnitude and orientation of the posterior cornea and/or the location of the incision axis is described. The magnitude and orientation of the posterior cornea can be calculated as a function of the measured pre-operative orientation of the steep meridian of the anterior cornea..
Abbott Medical Optics Inc.
02/26/15
20150056244

Antigens and vaccines directed against human enteroviruses


The instant invention provides materials and methods for producing immunologically active antigens derived from members of the picornaviridae virus family. The picornavirus antigens of the invention may be in a form for use as a vaccine administered to a subject in a therapeutic treatment or for the prevention of a picornavirus infection.
Sentinext Therapeutics Sdn Bhd
02/26/15
20150055081

Bimodular contact lenses


Ophthalmic lenses for correcting refractive error of an eye are disclosed. Ophthalmic lenses include an inner optic portion configured to be disposed over the optical region of the cornea and having a central portion disposed between an anterior portion and a posterior portion.
Nexisvision, Inc.
02/26/15
20150052662

Foldable and flexible head shade


A compact shade held over the head during inclement weather or to shield the sun. The shade has a simple circular or elongated loop of a thin strip of spring-like material covered by a sheet of one or more layers of soft, lightweight material.
02/19/15
20150051558

Composition and corneal proliferation


Disclosed herein in exemplary embodiments are methods and compositions for repairing or treating a defected cornea in a patient in need. The methods and compositions including, for example, administering a dose of a composition to the patient, wherein the composition comprises may be administered to an intraocular area of the patient via a container having a spout for ophthalmic delivery.
University Of Central Florida Research Foundation, Inc.
02/19/15
20150049004

Eye mounted displays and systems using eye mounted displays


A display device is mounted on and/or inside the eye. The eye mounted display contains multiple sub-displays, each of which projects light to different retinal positions within a portion of the retina corresponding to the sub-display.
02/12/15
20150045716

Intraocular pressure compensating and regulating valve


An intraocular pressure compensating and regulating valve installed inside the eye's cornea, comprising: a valve body having a valve seat at an end; a mobile element connected to the valve seat under normal intraocular pressure conditions inside the eye, the mobile element is configured such that it can be separated from the valve seat when the intraocular pressure exceeds the intraocular pressure limit; and an element to keep the mobile element in contact with the valve seat.. .
02/12/15
20150044446

Cellulose hydrogel compositions and contact lenses for corneal applications


The present invention provides cellulose hydrogels having one or more of the following properties: high water content, high transparency, high oxygen permeability, high biocompatibility, high tensile strength and desirable thermal stability. The present invention further provides a process for preparing a cellulose hydrogel comprising (i) a step of activating cellulose, in which the activating step comprises contacting the cellulose with a solvent to activate the cellulose for a time duration from about 2 hours to about 30 hours; (ii) substantially dissolving the activated cellulose to form a solution; and (iii) gelling the solution to form a gel, in which the gelling step comprises allowing the solution to gel in an environment comprising a relative humidity from about 30% to about 80% at 35° c..
The Johns Hopkins University
02/12/15
20150044178

Normalization of culture of corneal endothelial cells


The present invention provides a method for the normalized culturing of corneal endothelial cells. More specifically, the present invention provides a culture-normalizing-agent of a corneal endothelial cell, comprising a fibrosis inhibitor.
The Doshisha
02/12/15
20150042957

Objective phoropter system


Systems for performing combined phoropter and refractive measurements to ascertain the aberrations present in the eye of a subject. The systems use a pair of phoropter wheel assemblies, one for each eye, each assembly comprising a number of lens wheels incorporating the series of lenses and wedges required to compensate for a range of refractive vision aberrations.
Visionix Ltd.
02/12/15
20150042956

Observation device of cornea for transplantation, and auxiliary light source unit used for the same


An observation device includes: a holding board that holds an observation container accommodating a cornea for transplantation to be observed; a specular reflection optical system including an illumination optical system and an imaging optical system, which include a light source and an imaging unit, for observing the cornea for transplantation; and an auxiliary light source that illuminates the cornea for transplantation from the back and has an auxiliary illumination optical axis inclined with respect to an observation base axis that divides in half an intersecting angle of the illumination optical axis of the illumination optical system and an imaging optical axis of the imaging optical system, wherein the auxiliary light source is installed in a freely pivoting manner about a predetermined rotation axis so that a relative inclination angle with respect to the observation base axis of the auxiliary illumination optical axis can be continuously changed.. .
Konan Medical, Inc.
02/12/15
20150042477

Eye closure detection using structured illumination


A monitoring system and method for monitoring and/or predicting drowsiness of a driver of a vehicle or a machinery operator are provided. A set of infrared, ir, or near infrared, nir, light sources, is arranged such that an amount of the light emitted from the light source incidents on an eye of the driver or operator.
Tobii Technology Ab
02/05/15
20150038977

Apparatus and corneal marking


An instrument for use in aligning an intraocular lens (iol) comprises a marker ring rotatably held in a yoke attached to an instrument handle. The ring has an upper surface and a lower surface, and an inner surface and an outer surface.
02/05/15
20150038897

Low-profile microneedle patch applicator


A low-profile applicator, and a method of manufacturing and use thereof, for impacting microneedles against the stratum corneum of a person having a housing, a diaphragm member having the microneedles, a folding member having interlinking members that hinge-ably rotate with a force member, operatively attached thereto, between a resting position and an extended position. The folding member translates energy stored within the force member when release while retaining the force member in an energized state when in the resting position..
Zosano Pharma, Inc.
02/05/15
20150037287

Method of treating a malignancy in a subject and a pharmaceutical composition for use in same


There is a disclosed a method of killing abnormal cells such as malignant cells including melanoma cells, using a virus recognising at least one of a cell adhesion molecule and a complement regulatory protein. The virus may be a member of the picornaviridae family.
Viralytics Limited
01/29/15
20150032091

Second pass femtosecond laser for incomplete laser full or partial thickness corneal incisions


A method for forming an incision in an eye, the method including performing a first pass of a first laser beam along a path within an eye, wherein after completion of the first pass there exists a residual uncut layer at an anterior surface of a cornea of the eye. The method further including performing a second pass of a second laser beam only along a portion of the path that contains the residual uncut layer, wherein after completion of the second pass, the residual uncut layer is transformed into a full complete through surface incision..
Lensar, Inc.
01/29/15
20150030710

Compositions comprising extracts or materials derived from palm oil vegetation liquor for inhibition of vision loss due to angiogenesis and preparation there


The present invention relates generally to a composition comprising palm fruit juice for use in a method of preventing and inhibiting vision loss due to angiogenesis related diseases. The composition of the present invention aids to decrease in cnv size using confocal microscopy, in addition to reduction in macrophage infiltration using immune staining; decrease in vegf-a-induced angiogenesis using established cornea pocket assay, inhibition of ikb-d phosphorylation in laser treated choroidal tissues and reduction in macrophage recruitment to cnv lesions..
Malaysian Palm Oil Board
01/29/15
20150027093

Air cleaner assembly; components therefor; and, methods


Air filter cartridges for use in air cleaner assemblies are described. The air filter cartridges typically comprise a stack of strips of fluted media, having an inlet flow face and an outlet flow face.
Donaldson Company, Inc.
01/22/15
20150025510

Laser device and process for configuring such laser device


A process for configuring a laser device comprising: selecting a pulse length within a range from 1 ps to 1 ns; selecting a wavelength for the laser radiation within a range from 300 nm to 400 nm or within a range from 800 nm to 1100 nm; ascertaining a set of parameter values of the laser device that when the laser device is operated with these parameter values a two-dimensionally extensive separation of tissue of human corneal or lenticular tissue is achieved by stringing together local sites of damage, the set of parameter values including the selected pulse length, the selected wavelength, and values for at least one of the following parameters: a pulse energy, a pulse repetition rate, a fluence per radiation pulse, a number of pulses per site of damage, a scanning speed of a scanning apparatus of the laser device, and a focus diameter.. .
Wavelight Gmbh
01/22/15
20150025481

Pocketable biodegradable powder application device


A pocketable biodegradable powder application device having a cardboard backer component affixed to the backside of which is a cardboard handle component and having adjacent to the frontside of the backer component, a first piece component made up of cotton batten material and having anteriorly adjacent to the first piece component, a frontal membrane component through which grains of cornstarch powder material held between it and the first piece component can pass whenever the device is pressed against the skin of a hospital patient, with the backer component, the first piece component and the frontal membrane component all being adhesively affixed to one another about the perimeters of each, once powder material would have been positioned in between the first piece component and the frontal membrane component; and with the intact application device being readily amenable to being held within a pocket unit made of paper material.. .
01/22/15
20150025459

Multi-site injection system


A multi-site injection system includes a plurality of medicament delivering needles/microprotrusions, a needle/microprotrusion support, a supply of medicament, and a mechanism for providing the medicament to the plurality of needles/microprotrusions in order to effect delivery into a stratum corneum of a user.. .
Allergan, Inc.
01/22/15
20150025440

Eye therapy system


Embodiments apply a cross-linking agent to a region of corneal tissue. The cross-linking agent improves the ability of the corneal tissue to resist undesired structural changes.
Avedro, Inc.
01/22/15
20150025221

Skin permeating and cell entering (space) peptides and methods of use thereof


The present disclosure provides peptides and peptide compositions, which facilitate the delivery of an active agent or an active agent carrier wherein the compositions are capable of penetrating the stratum corneum (sc) and/or the cellular membranes of viable cells.. .
The Regents Of The University Of California
01/15/15
20150018674

Corneal topography measurement and alignment of corneal surgical procedures


Methods and apparatus are configures to measure an eye without contacting the eye with a patient interface, and these measurements are used to determine alignment and placement of the incisions when the patient interface contacts the eye. The pre-contact locations of one or more structures of the eye can be used to determine corresponding post-contact locations of the one or more optical structures of the eye when the patient interface has contacted the eye, such that the laser incisions are placed at locations that promote normal vision of the eye.
Optimedica Corporation
01/15/15
20150018661

Non-contact system for measuring corneal properties and measuring corneal elastic constant and viscosity constant


A method for measuring corneal elastic constant and viscosity constant comprises steps of: ejecting compressed air toward a cornea of a live eye ball and measuring air pressure thereof; emitting infrared rays during an air ejecting period, for measuring corneal deformation caused by the compressed air applied to the cornea; and calculating an elastic constant and a viscosity constant of the cornea based on kelvin-voigt model by utilizing the corneal deformation measured via the infrared rays and the measured air pressure during the air ejecting period. One advantage of the present invention is to aid preliminary detection in eye diseases..
National Taiwan University
01/15/15
20150015847

Capacitive eye tracking sensor


An apparatus (100), comprising a transparent capacitive sensor (102); a body (101) configured to support the transparent capacitive sensor in front of an eye (112) of a user (110); and a driver (106) configured to receive signals from the sensor and to determine eye movements based on the received signals, wherein the sensor (102) is configured to detect movement of the eye (112) based on electrostatic effect caused by a bulge of the cornea of the eye (112). The apparatus may be wearable by the user like eyeglasses..
Nokia Corporation
01/15/15
20150015814

Spatial focal field type glasses display


A spatial focal field type glasses display product can present virtual images at different distances simultaneously. The product is a frame type glasses or corneal contact lens and comprises a projection component and a display control device.
Beijing Antvr Technology Co., Ltd.
01/08/15
20150011984

Corneal visual center localizer (or locator)


Daifs corneal visual center (cvc) localizer (locator) is a point light source of infra red (ir) light, attached and fixed to any eximer laser machine, located at equal distance and in exactly opposite direction from the middle of a detecting camera that detects ir light reflection from the corneal surface and the pupillary margin of the iris with a point fixation target or its virtual extension, perpendicular to the plan containing the localizer and the middle point the inlet of the detecting camera, exactly in the middle of the distance between the localizing point light source and the middle point the detecting camera. With the localizer in position and activated, the cvc will be seen on the screen of ir eye tracking as a white dot somewhere inside the white circle that represents the detected pupillary margin.
01/08/15
20150011570

Transdermal delivery of beneficial substances effected by a hostile biophysical environment


The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical environment. In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed.
Strategic Science & Technologies, Llc
01/08/15
20150011475

Method for screening an agent being useful for the treatment of dry eye and /or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method


The present invention provides a method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion of dry eye severity level 3 or more according to the report of the international dry eye workshop (dews report) (2007) and a pharmaceutical composition comprising the agent. The present invention further provides a method for the treatment of dry eye and/or corneal and conjunctival lesion of dry eye severity level 3 or more according to dews report (2007) using the agent..
R-tech Ueno, Ltd.


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Corn for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Corn with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         











0.4388

3267

1 - 1 - 74